Press release
Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 - By Report, Size, Share, Industry Growth, Forecast To 2033
Proliferative Diabetic Retinopathy (PDR) Market
As per the report, the proliferative diabetic retinopathy (pdr) market size has grown rapidly in recent years. It will grow from $2.16 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The proliferative diabetic retinopathy (pdr) market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market
The rising prevalence of diabetes is expected to propel the growth of the proliferative diabetic retinopathy (PDR) market going forward. Diabetes is a chronic medical condition characterized by elevated glucose (sugar) levels in the blood. Diabetes is the leading cause of proliferative diabetic retinopathy disease, which can be treated by various methods that prevent further damage to the retina and preserve vision. For instance, in 2021, according to the International Diabetes Federation (IDF), a Belgium-based organization, 537 million adults aged between 20-79 are suffering from diabetes (1 in 10 people) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes drives the proliferative diabetic retinopathy (PDR) market.
Innovative Therapies Revolutionize Proliferative Diabetic Retinopathy Treatment Landscape
Major companies operating in the proliferative diabetic retinopathy market continuously focus on developing novel therapies to enhance treatment effectiveness, reduce treatment burden and improve patient outcomes. For example, in June 2022, Biogen, a US-based biotechnology company and Samsung Bioepis, a South Korea-based biotech company, introduced Byooviz (ranibizumab-nuna), the first ophthalmology biosimilar in the US. These products are used to treat patients with diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD) and choroidal neovascularization.
The proliferative diabetic retinopathy (pdr) market covered in this report is segmented -
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy; Intraocular Steroids; Laser Surgery; Vitrectomy
2) By Mode of Administration: Injectables; Oral; Other Mode Of Administrations
3) By Application: Hospitals; Clinics; Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12911&type=discount
Major players in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.
Contents of the report:
1. Executive Summary
2. Proliferative Diabetic Retinopathy (PDR) Market Report Structure
3. Proliferative Diabetic Retinopathy (PDR) Market Trends And Strategies
4. Proliferative Diabetic Retinopathy (PDR) Market - Macro Economic Scenario
5. Proliferative Diabetic Retinopathy (PDR) Market Size And Growth
…..
27. Proliferative Diabetic Retinopathy (PDR) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 - By Report, Size, Share, Industry Growth, Forecast To 2033 here
News-ID: 3616932 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for PDR
Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopat …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Proliferative Diabetic Retinopathy (PDR) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for proliferative diabetic retinopathy (pdr) has experienced swift expansion lately, projected to increase from $2.42 billion in 2024 to reach $2.69 billion by 2025, reflecting an 11.3% compound annual growth rate…
Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Proliferative Diabetic Retinopathy (PDR) Market Through 2025?
The market for proliferative diabetic retinopathy (PDR) has seen robust expansion in the past few years. The growth is projected to rise from $2.42 billion in 2024 to $2.7 billion in 2025, with a compound…
Proliferative Diabetic Retinopathy (PDR) Market Size And Share Report, 2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.62 billion In…
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title India Airway Stenting Procedures Outlook to 2023 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017, provides an overview of the Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline landscape.
Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic…
Proliferative Diabetic Retinopathy (PDR): Pipeline Assessment of Vital Drugs & M …
In the recent times, the diabetic retinopathy therapeutic market is witnessing a bigger growth owing to the rise in a number of patients with this diabetic related ailment. To focus on this market growth, a fresh study has been included into the vast repository of online collection under Market Research Hub (MRH), and titled, ‘’Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017‘’. The report is a complete pipeline guide…
Proliferative Diabetic Retinopathy (PDR) Market H1 2017 Pipeline Review Report
Proliferative Diabetic Retinopathy market Pipeline Review, H1 2017, provides an overview of the Proliferative Diabetic Retinopathy (Oncology) pipeline landscape. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Complete report on http://www.reportsnreports.com/reports/983989-proliferative-diabetic-retinopathy-pdr-pipeline-review-h1-2017.html
Pharmaceutical and Healthcare latest pipeline guide Proliferative Diabetic Retinopathy Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Proliferative Diabetic Retinopathy complete…
